← Back to Clinical Trials
Recruiting NCT07478666

NCT07478666 Feasibility of Remotely Measured Activity Behavior for Individuals With Functional Neurologic Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07478666
Status Recruiting
Phase
Sponsor University of Colorado, Denver
Condition Functional Neurological Disorder
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2026-04-16
Primary Completion 2027-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2026-04-16 with a primary completion date of 2027-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study evaluates whether remotely measured daily activity behavior, captured through a thigh-worn accelerometer, can serve as a reliable and ecologically valid indicator of symptom impact in individuals with Functional Neurologic Disorder (FND). Current clinician-rated assessments capture only a single time point and do not reflect day-to-day symptom variability or functional impact. The study will (1) assess the feasibility of continuous activity monitoring in people with FND, (2) examine associations between activity behavior and established clinician- and patient-reported FND measures, and (3) qualitatively explore participants' lived experiences of daily activity. Findings aim to address a critical gap in understanding real-world function in this heterogeneous population.

Eligibility Criteria

Inclusion Criteria: Participants with FND: •Neurologist-confirmed diagnosis of functional neurologic disorder with motor symptoms, sensory symptoms, dizziness, and/or seizures Healthy Controls: * Roughly matched to participants with FND for age and sex * Free from major disease that affects mobility (e.g., neurologic, movement, cardiac, pulmonary, renal, and psychiatric disorders) by history. Exclusion Criteria: Participants with FND * Physical or cognitive symptoms impairing ability to engage with the protocol (e.g., seizure frequency \> 10/day). * Diagnosis of other major neurologic, cardiovascular, musculoskeletal, or psychiatric disorder that affects mobility as determined by the principal investigator

Contact & Investigator

Central Contact

Elliot J Gann, DPT

✉ elliot.gann@cuanschutz.edu

📞 650-282-0897

Frequently Asked Questions

Who can join the NCT07478666 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Functional Neurological Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07478666 currently recruiting?

Yes, NCT07478666 is actively recruiting participants. Contact the research team at elliot.gann@cuanschutz.edu for enrollment information.

Where is the NCT07478666 trial being conducted?

This trial is being conducted at Denver, Canada.

Who is sponsoring the NCT07478666 clinical trial?

NCT07478666 is sponsored by University of Colorado, Denver. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology